Patent · US Expired

Pharmaceutical compounds

US6235717A · kind A · utility

45Cited by

8References

17Claims

0Family size

Assignee

Glaxo Wellcome Inc. · US

Inventors

Johann Leban · Planegg, DE
Douglas B. Sherman · Durham, US
James Frederick Sigafoos · Durham, US
Andreas Spaltenstein · Raleigh, US
Osvaldo Humberto Viveros · Chapel Hill, US
David Wan · Hong Kong, CN

Key dates

Filing date	Jul 3, 1995
Grant date	May 22, 2001
Priority date	—
Expiry date	Jul 3, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) or a salt thereof ##STR1## as well as methods of making and using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.